<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have identified one frameshift mutation, one splice-site mutation, and two missense mutations in highly conserved residues in ZDHHC9 at Xq26.1 in 4 of 250 families with <z:hpo ids='HP_0001417'>X-linked</z:hpo> <z:hpo ids='HP_0001249'>mental retardation</z:hpo> (XLMR) </plain></SENT>
<SENT sid="1" pm="."><plain>In three of the families, the <z:hpo ids='HP_0001249'>mental retardation</z:hpo> phenotype is associated with a <z:hpo ids='HP_0001519'>Marfanoid habitus</z:hpo>, although none of the affected individuals meets the Ghent criteria for <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>ZDHHC9 is a palmitoyltransferase that catalyzes the posttranslational modification of NRAS and HRAS </plain></SENT>
<SENT sid="3" pm="."><plain>The degree of palmitoylation determines the temporal and spatial location of these proteins in the plasma membrane and Golgi complex </plain></SENT>
<SENT sid="4" pm="."><plain>The finding of mutations in ZDHHC9 suggests that alterations in the concentrations and cellular distribution of target proteins are sufficient to cause disease </plain></SENT>
<SENT sid="5" pm="."><plain>This is the first XLMR gene to be reported that encodes a posttranslational modification enzyme, palmitoyltransferase </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, now that the first palmitoyltransferase that causes <z:hpo ids='HP_0001249'>mental retardation</z:hpo> has been identified, defects in other palmitoylation transferases become good candidates for causing other <z:hpo ids='HP_0001249'>mental retardation</z:hpo> syndromes </plain></SENT>
</text></document>